Loading insider details...
Beta
Latest Form 4 (Feb 2, 2026): Grant/Award of 183,750 MREO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 2, 2026 | Mereo BioPharma Group plc (MREO) | Grant/Award | 183,750 | n/a |
| Jan 28, 2025 | Mereo BioPharma Group plc (MREO) | Grant/Award | 154,000 | n/a |
| Sep 17, 2024 | Mereo BioPharma Group plc (MREO) | Sale | 7,769 | $34.7K |
| Sep 13, 2024 | Mereo BioPharma Group plc (MREO) | Exercise/Conversion | 40,000 | n/a |
| Jun 27, 2024 | Mereo BioPharma Group plc (MREO) | Sale | 10,134 | $37.4K |
| Jun 25, 2024 | Mereo BioPharma Group plc (MREO) | Exercise/Conversion | 60,000 | n/a |
| May 24, 2024 | Mereo BioPharma Group plc (MREO) | Exercise/Conversion | 93,333 | $130.7K |
| Jan 26, 2024 | Mereo BioPharma Group plc (MREO) | Grant/Award | 196,000 | n/a |